NVIDIA Advances Biomolecular Modeling With New Framework

Key Moments

NVIDIA’s BioNeMo team has introduced context parallelism, a framework that distributes a single large biomolecular system across multiple GPUs to overcome memory constraints.
A proof-of-concept demonstration folded a biomolecular complex with over 3,600 residues on four GPUs in under five minutes while preserving structural accuracy.
Companies including Rezo Therapeutics, Proxima, and Earendil Labs are already applying context parallelism to model large, complex protein systems for drug discovery and therapeutic research.

Redefining GPU Limits in Computational Biology

For many years, computational biologists have faced a persistent bottleneck: the finite memory available on individual GPUs. When simulating large biomolecular assemblies, such as protein complexes containing thousands of residues, researchers often had to break these systems into smaller segments. That fragmentation made it difficult to preserve full structural context, limiting insight into critical long-range biological interactions.

NVIDIA’s BioNeMo team has now introduced a major advance to address this challenge. The new context parallelism (CP) framework enables end-to-end simulation of very large biomolecular structures by distributing a single system across multiple GPUs, rather than assigning different tasks to each device. This design directly targets GPU memory constraints while preserving the holistic view of the system.

How Context Parallelism Overcomes Memory Constraints

Traditional approaches to handling large protein sequences relied on techniques such as fragmenting sequences or aggressive memory optimizations like chunking. Although these methods helped individual GPUs accommodate big workloads, they often degraded long-range structural fidelity and limited the ability to model full-system behavior.

The CP framework changes this paradigm by sharding a single biomolecular structure across several GPUs. Instead of each GPU working independently on separate tasks, they share responsibility for one large system. This allows the total computational capacity to scale in proportion to the number of GPUs while maintaining a consistent view of the global structure.

The implementation uses NVIDIA H100 and B300 GPU clusters in combination with PyTorch Distributed APIs. By organizing protein structural information over a GPU grid, CP localizes memory use so no individual device must store the entire model. As a result, researchers can now simulate systems with tens of thousands of residues, far exceeding prior practical limits.

Core Technical Innovations in the CP Framework

The CP architecture incorporates multiple technical mechanisms designed to improve scalability and efficiency.

Innovation	Description	Impact
2D Tiling	Protein interaction matrices are partitioned into smaller sub-blocks.	Reduces memory requirements from O(N^2) to O(N^2/P), where P is the number of GPUs.
Overlapping Computation and Communication	GPUs carry out local computations while concurrently exchanging data with neighboring devices.	Improves efficiency as model size grows by hiding communication latency behind computation.
Efficient Local Attention	Distributed primitives are used to limit communication overhead during attention operations.	Enables handling very long token sequences without excessive inter-GPU data transfer.

In a proof-of-concept demonstration, NVIDIA applied CP to fold a large biomolecular assembly with more than 3,600 residues. Using four GPUs, the system completed the folding process in under five minutes and maintained structural fidelity, highlighting the framework’s potential to scale without compromising accuracy.

Adoption Across the Biotech and Therapeutics Ecosystem

Several organizations are already deploying the CP framework to tackle biomolecular problems that were previously too large or complex to handle effectively.

Rezo Therapeutics – Leveraged CP to simulate protein-protein interactions involving up to 6,500 residues, supporting the identification of new molecular complexes.
Proxima – Incorporated CP into its Neo generative model, enabling more detailed structural views of interactions relevant to therapeutic development.
Earendil Labs – Extended CP to study highly complex systems made up of multiple proteins, helping shorten timelines in biotherapeutic discovery.

Advancing Model Accuracy and Training at Scale

Despite the substantial gains in computational capacity, NVIDIA emphasizes that improved hardware utilization alone does not guarantee accurate biological predictions. Many existing models were trained primarily on smaller protein segments, which may limit their ability to fully represent long-range interactions in large assemblies.

To close this gap, NVIDIA is enhancing data resources for training larger-scale models. The company is contributing to the AlphaFold Protein Structure Database and deploying accelerated tools, including cuEquivariance and TensorRT, to expand and optimize structural datasets for future training runs.

Accessing Context Parallelism Resources

Researchers who want to explore or implement the CP framework can consult the open-source documentation provided through the Boltz CP GitHub repository. Additional technical depth is available in the Fold-CP research paper, which details the methods and performance characteristics of the approach.